reaction was successful even without masking the phenolic
hydroxyl. The modern procedures developed by the groups
of Ma6 and Buchwald7 were tried. It was found that Ma’s
method is very convenient for coupling with amines (7 f
8, 15, 19; 26 f 27), while Buchwald’s procedure was
excellent for coupling with amides (7 f 23; 26 f 32). Under
Ma’s conditions (CuI, L-proline, DMSO, K2CO2, 55-85 °C),
the iodophenol or its MOM ether was converted smoothly
into the corresponding secondary amine, which was then
processed either by N-acylation and formation of the iodide,
or by the reverse sequence, formation of the iodide followed
by N-acylation. Use of Buchwald’s method gave 23 and 32,
which were directly converted into iodides 24 and 33,
respectively. Our experiments demonstrate the compatibility
of these copper-mediated reactions6,7 with unprotected al-
cohols and, in some cases, free phenols, a characteristic that
is clearly a useful feature.
and alkyl groups appear to be unsuitable in this regard, at
least as judged by experiments with 5a-c and 6. However,
MeOCO-, allylOCO-, CF3CO-, and PhOCO- are satis-
factory, and oxidation was easily achieved also in the case
of 25 (Scheme 3), which is equivalent to an intramolecularly
protected amine.
The oxidations were done using PhI(OAc)2, PhI(O-
COCF3)2, or PhIO and were also successful with the amides
33 (see Scheme 3) and 4.1 (Scheme 4).11
Unlike the oxidation of p-alkoxyphenols to quinone acetals
(cf. 1.1 f 1.2, Scheme 1), the corresponding transformation
of p-aminophenols (cf. 2.1 f 2.2, Scheme 2) is not well-
known, the only relevant examples being found in synthetic
work on dynemicin A (Scheme 4, 3.1 f 3.2)8 and in a report
Iodides 2.1 were prepared from the corresponding alcohols
using the Ph3P-I2-imidazole combination,12 and we have
carried out the alcohol f iodide conversion either before (8
f 9, 15 f 16) or after N-acylation (12 f 13, 20 f 21, 28
f 29, 30 f 31). In the case of the conversion 20 f 21,
generation of the iodide was successful only with phenyl
carbamate protection. Where appropriate, MOM protecting
groups were removed with Me3SiBr prior to oxidation.
Radical cyclization under standard high-dilution conditions13
worked well in all cases, except for 33a, which, like 4.2,
was stable only in the solid state or in acidic MeOH but
decomposed under other conditions.
Scheme 4
The aromatization step (cf. 2.3 f 2.4) can, in principle,
proceed in two ways, depending on whether the methoxy
group (2.3 f 2.4, Scheme 2) or the amino unit is expelled;
fortunately, the desired loss of the methoxy group is the only
pathway we observe under our optimized conditions.14
that 4.1 is convertible into 4.2 on treatment with PhI(OAc)2
(Scheme 4).9,10 We evaluated a number of nitrogen protecting
groups and found that not all of them allow the chemical
oxidation 2.1 f 2.2: p-toluenesulfonyl, t-butoxycarbonyl,
Scheme 5a
(2) (a) Axon, J.; Boiteau, L.; Boivin, J.; Forbes, J. E.; Zard, S. Z.
Tetrahedron Lett. 1994, 35, 1719-1722. (b) Liard, A.; Quiclet-Sire, B.;
Saicic, R.; Zard, S. Z. Tetrahedron Lett. 1997, 38, 1759-1762. (c) Cholleton,
N.; Zard, S. Z. Tetrahedron Lett. 1998, 39, 7295-7298. (d) Hoang-Cong,
X.; Quiclet-Sire, B.; Zard, S. Z. Tetrahedron Lett. 1999, 40, 2125-2126.
(e) Ly, T.-M.; Quiclet-Sire, B.; Sortais, B.; Zard, S. Z. Tetrahedron Lett.
1999, 40, 2533-2536. (f) Kaoudi, T.; Quiclet-Sire, B.; Seguin, S.; Zard, S.
Z. Angew. Chem., Int. Ed. 2000, 39, 731-733. (g) Quiclet-Sire, B.; Sortais,
B.; Zard, S. Z. J. Chem. Soc., Chem. Commun. 2002, 1692-1693. (h)
Quiclet-Sire, B.; Zard, S. Z. J. Chem. Soc., Chem. Commun. 2002, 2306-
2307. (i) Zard, S. Z. Angew. Chem., Int. Ed. Engl. 1997, 36, 672-685.
(3) (a) Menes-Arzate, M.; Mart´ınez, R.; Cruz-Almanza, R. Muchowski,
J. M.; Osornio, Y. M.; Miranda, L. D. J. Org. Chem. 2004, 69, 4001-
4004. (b) For other leading references, see ref 4.
a Reagents and conditions: (a) (i) Allyl-magnesium bromide,
THF; (ii) TsOH‚H2O, 4 Å molecular sieves, CH2Cl2, 71%.
(4) Clive, D. L. J.; Fletcher, S. P.; Liu, D. J. Org. Chem. 2004, 69, 3282-
As in the formation of benzo-fused oxygen heterocycles
(Scheme 1), the present method can be modified to generate
compounds carrying hydrogen or a carbon substituent instead
3293.
(5) For example, see the following. Kinase inhibitors: Smithkline
Beecham, WO 2004043379, 2004. Histamine H3 receptor antagonists: Eli
Lilly, WO 2004026837, 2004. 2,3-Oxidosqualene-lanosterol cyclase inhibi-
tors: Hoffmann-La Roche, WO 2002050041, 2002. Growth hormone release
promoters: Sumimoto Pharmaceuticals, JP 11292894, 1999. Treatment for
dementia: U.S. Department of Health and Human Services, WO 2002048150,
2002. Dopamine D4 receptors: H. Lundbeck A/S, WO 9828293, 1998.
Estrogen receptor modulators: Eli Lilly, WO 2002094788, 2002.
(6) Ma, D.; Cai, Q.; Zhang, H. Org. Lett. 2003, 5, 2453-2455.
(7) Klapars, A.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2002,
124, 7421-7428.
(8) (a) Yoon, T.; Shair, M. D.; Danishefsky, S. J. Tetrahedron Lett. 1994,
35, 6259-6262. (b) Shair, M. D., Yoon, T. Y.; Mosnie, K. K.; Chou, T.
C.; Danishefsky, S. J. J. Am. Chem. Soc. 1996, 118, 9509-9525. (c) Myers,
A. G.; Tom, N. J.; Fraley, M. E.; Cohen, S. B.; Madar, D. J. J. Am. Chem.
Soc. 1997, 119, 6072-6094.
(9) Fleck, A. E.; Hobart, J. A.; Morrow, G. W. Synth. Commun. 1992,
22, 179-187.
Org. Lett., Vol. 7, No. 1, 2005
25